Dr Nadia Koloteva-Levine is a molecular biologist and Senior Fellow of Advance HE, currently based at the University of Kent. She holds a PhD in Molecular Biology and Genetics from UMIST (Manchester, UK). Since joining Kent in 2019, she has lectured in Molecular Biosciences and now leads the Advanced Therapy Medicinal Products (ATMP) programme within the Apprenticeship Centre.